In fact, some studies have shown that conditional loss of SMAD4 or TGFBR2 in Pdx1-Cre/LSL-KRas mice develop advanced aggressive pancreatic cancer [76]. This evidence concerns the gene SMAD4 and pancreatic neoplasm.